Search results
Results from the WOW.Com Content Network
Convergence insufficiency. Convergence Insufficiency. Other names. Convergence disorder. Specialty. Ophthalmology, optometry. Convergence insufficiency is a sensory and neuromuscular anomaly of the binocular vision system, characterized by a reduced ability of the eyes to turn towards each other, or sustain convergence .
Prism correction is commonly specified in prism dioptres, a unit of angular measurement that is loosely related to the dioptre. Prism dioptres are represented by the Greek symbol delta (Δ) in superscript. A prism of power 1 Δ would produce 1 unit of displacement for an object held 100 units from the prism. [2]
Heterophoria is an eye condition in which the directions that the eyes are pointing at rest position, when not performing binocular fusion, are not the same as each other, or, "not straight". This condition can be esophoria, where the eyes tend to cross inward in the absence of fusion; exophoria, in which they diverge; or hyperphoria, in which ...
Getting a diabetes test can help you get a proper diagnosis. Here, doctors explain how to test for diabetes, gestational diabetes tests, general A1C, and more.
Nearly all patients with type 1 diabetes and >60% of patients with type 2 diabetes [3] Diabetic retinopathy (also known as diabetic eye disease ), is a medical condition in which damage occurs to the retina due to diabetes. It is a leading cause of blindness in developed countries. Diabetic retinopathy affects up to 80 percent of those who have ...
Diplopia is diagnosed mainly by information from the patient. Doctors may use blood tests, physical examinations, computed tomography (CT), or magnetic resonance imaging (MRI) to find the underlying cause. Classification. One of the first steps in diagnosing diplopia is often to see whether one of two major classifications may be eliminated.
Ambulatory glucose profile ( AGP) is a single-page, standardized report for interpreting a patient's daily glucose and insulin patterns. AGP provides both graphic and quantitative characterizations of daily glucose patterns. First developed by Drs. Roger Mazze and David Rodbard, [1] with colleagues at the Albert Einstein College of Medicine in ...
Novo Nordisk's Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes and lowered the risk of kidney failure, heart problems, stroke and death, according to detailed ...